Gracon SI - Search Results

1

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, et al. Davis KL, et al. Among authors: gracon si. N Engl J Med. 1992 Oct 29;327(18):1253-9. doi: 10.1056/NEJM199210293271801. N Engl J Med. 1992. PMID: 1406817 Free article. Clinical Trial.

2

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group.

Knopman D, Schneider L, Davis K, Talwalker S, Smith F, Hoover T, Gracon S. Knopman D, et al. Neurology. 1996 Jul;47(1):166-77. doi: 10.1212/wnl.47.1.166. Neurology. 1996. PMID: 8710072 Clinical Trial.

3

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. Knapp MJ, et al. Among authors: gracon si. JAMA. 1994 Apr 6;271(13):985-91. JAMA. 1994. PMID: 8139083 Clinical Trial.

4

Steady-state pharmacokinetics of tacrine in patients with Alzheimer's disease.

Cutler NR, Sedman AJ, Prior P, Underwood BA, Selen A, Balogh L, Kinkel AW, Gracon SI, Gamzu ER. Cutler NR, et al. Among authors: gracon si. Psychopharmacol Bull. 1990;26(2):231-4. Psychopharmacol Bull. 1990. PMID: 2236461

5

Long-term tacrine treatment effects.

Knopman D, Schneider L, Davis K, Gracon S, Smith F. Knopman D, et al. Neurology. 1998 Feb;50(2):567-8. doi: 10.1212/wnl.50.2.567. Neurology. 1998. PMID: 9484404 Clinical Trial. No abstract available.

6

The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

Knopman DS, Knapp MJ, Gracon SI, Davis CS. Knopman DS, et al. Among authors: gracon si. Neurology. 1994 Dec;44(12):2315-21. doi: 10.1212/wnl.44.12.2315. Neurology. 1994. PMID: 7991118 Clinical Trial.

7

Next generation tacrine.

Schwarz RD, Davis RE, Gracon S, Hoover T, Moos WH, Pavia MR. Schwarz RD, et al. Neurobiol Aging. 1991 Mar-Apr;12(2):185-7. doi: 10.1016/0197-4580(91)90060-w. Neurobiol Aging. 1991. PMID: 2052133 Review. No abstract available.

8

Tacrine in Alzheimer's disease.

Gracon SI. Gracon SI. N Engl J Med. 1993 Mar 18;328(11):808-9. N Engl J Med. 1993. PMID: 8437605 No abstract available.

9

A double-blind, placebo-controlled, enriched population study of tacrine in patients with Alzheimer's disease.

Forette F, Hoover T, Gracon S, de Rotrou J, Hervy MP, Lechevalier B, Micas M, Petit H, Orgogozo JM, Guard O, Saudeau D, Forette B, Michel B, Emile J, Augustin P, Wang A, Vignat J, Allain H, Cuny G, Leger JM, Collard M, Joyeux O, Khalil R. Forette F, et al. Eur J Neurol. 1995 Jul;2(3):229-38. doi: 10.1111/j.1468-1331.1995.tb00124.x. Eur J Neurol. 1995. PMID: 24283645

10

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Jack CR Jr, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, Xu Y, Shiung M, O'Brien PC, Cha R, Knopman D, Petersen RC. Jack CR Jr, et al. Neurology. 2003 Jan 28;60(2):253-60. doi: 10.1212/01.wnl.0000042480.86872.03. Neurology. 2003. PMID: 12552040 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page